UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 262

Sortiert nach

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

Gut, 2021-07, Vol.70 (7), p.1375

2021

Link zum Volltext

Verfügbarkeit prüfen

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Hepatology (Baltimore, Md.), 2015-05, Vol.61 (5), p.1547-1554

2015

Link zum Volltext

Verfügbarkeit prüfen

Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease

Journal of hepatology, 2020-11, Vol.73 (5), p.1023-1029

2020

Link zum Volltext

Verfügbarkeit prüfen

A new model for estimation of significant fibrosis in primary care. SAFE to use?

Hepatology (Baltimore, Md.), 2023-01, Vol.77 (1), p.18-19

Hagstrom, H

2023

Link zum Volltext

Verfügbarkeit prüfen

Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort

Gut, 2022-09, Vol.71 (9), p.1867

2022

Link zum Volltext

Verfügbarkeit prüfen

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

Journal of hepatology, 2017-12, Vol.67 (6), p.1265-1273

2017

Link zum Volltext

Verfügbarkeit prüfen

Risk of fractures and subsequent mortality in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study

Journal of internal medicine, 2022-09, Vol.292 (3), p.492-500

2022

Link zum Volltext

Verfügbarkeit prüfen

Less is more? Screening for steatosis in older populations

Hepatology (Baltimore, Md.), 2023-02, Vol.77 (2), p.350-351

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study

Liver international, 2022-04, Vol.42 (4), p.820-828

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial: can urine‐based metabolomics improve diagnosis of advanced fibrosis in NAFLD?

Alimentary pharmacology & therapeutics, 2020-06, Vol.51 (11), p.1204-1205

Hagstrom, H

2020

Link zum Volltext

Verfügbarkeit prüfen

Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease

Gastroenterology (New York, N.Y. 1943), 2020-01, Vol.158 (1), p.200-214

2020

Link zum Volltext

Verfügbarkeit prüfen

Editorial: moving from the clinic towards population hepatology—authorsʼ reply

Alimentary pharmacology & therapeutics, 2023-03, Vol.57 (6), p.728-728

2023

Link zum Volltext

Verfügbarkeit prüfen

Changing epidemiology, global trends and implications for outcomes of NAFLD

Journal of hepatology, 2023-09, Vol.79 (3), p.842-852

2023

Link zum Volltext

Verfügbarkeit prüfen

Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects

Clinical gastroenterology and hepatology, 2023-05, Vol.21 (5), p.1359-1361.e2

2023

Link zum Volltext

Verfügbarkeit prüfen

Maternal obesity increases the risk and severity of NAFLD in offspring

Journal of hepatology, 2021-11, Vol.75 (5), p.1042-1048

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study

Clinical gastroenterology and hepatology, 2023-05, Vol.21 (5), p.1271-1280.e7

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk of cardiovascular disease and loss in life expectancy in NAFLD

Hepatology (Baltimore, Md.), 2022-11, Vol.76 (5), p.1495-1505

2022

Link zum Volltext

Verfügbarkeit prüfen

Cancer Risk in Patients With Biopsy‐Confirmed Nonalcoholic Fatty Liver Disease: A Population‐Based Cohort Study

Hepatology (Baltimore, Md.), 2021-11, Vol.74 (5), p.2410-2423

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk for hepatic and extra‐hepatic outcomes in nonalcoholic fatty liver disease

Journal of internal medicine, 2022-08, Vol.292 (2), p.177-189

2022

Link zum Volltext

Verfügbarkeit prüfen

Alcohol, smoking and the liver disease patient

Baillière's best practice & research. Clinical gastroenterology, 2017-10, Vol.31 (5), p.537-543

Hagstrom, H

2017

Link zum Volltext

Verfügbarkeit prüfen

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.1611-1625.e12

2020

Link zum Volltext

Verfügbarkeit prüfen

Overweight in late adolescence predicts development of severe liver disease later in life: A 39 years follow-up study

Journal of hepatology, 2016-08, Vol.65 (2), p.363

2016

Link zum Volltext

Verfügbarkeit prüfen

Defining comprehensive models of care for NAFLD

Nature reviews. Gastroenterology & hepatology, 2021-10, Vol.18 (10), p.717-729

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – a randomised controlled trial

JHEP reports, 2021-06, Vol.3 (3), p.100256, Article 100256

2021

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease

Clinical gastroenterology and hepatology, 2019-05, Vol.17 (6), p.1148-1156.e4

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(258)
Mit Volltextzugriff
(241)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease

A new model for estimation of significant fibrosis in primary care. SAFE to use?

Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

Risk of fractures and subsequent mortality in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study

Less is more? Screening for steatosis in older populations

Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study

Editorial: can urine‐based metabolomics improve diagnosis of advanced fibrosis in NAFLD?

Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease

Editorial: moving from the clinic towards population hepatology—authorsʼ reply

Changing epidemiology, global trends and implications for outcomes of NAFLD

Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects

Maternal obesity increases the risk and severity of NAFLD in offspring

Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study

Risk of cardiovascular disease and loss in life expectancy in NAFLD

Cancer Risk in Patients With Biopsy‐Confirmed Nonalcoholic Fatty Liver Disease: A Population‐Based Cohort Study

Risk for hepatic and extra‐hepatic outcomes in nonalcoholic fatty liver disease

Alcohol, smoking and the liver disease patient

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Overweight in late adolescence predicts development of severe liver disease later in life: A 39 years follow-up study

Defining comprehensive models of care for NAFLD

Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – a randomised controlled trial

Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease

Suchergebnisse filtern